HEATHER VAN DUYS: Open Payments
NPI 1003242926 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 23 payments from 10 companies in 2025. Trend: 2023 $911 · 2024 $1,079 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $236 |
| Madrigal Pharmaceuticals | 4 | $225 |
| CONMED Corporation | 1 | $140 |
| Celltrion USA Inc. | 3 | $76 |
| Mallinckrodt Hospital Products Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Sandoz Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
Products named: REZDIFFRA, CONMED HEMOSTASIS, RINVOQ, VEGZELMA, TERLIVAZ, INJECTAFER, HYRIMOZ, GATTEX.
Industry payments across GA — which companies pay providers there.
